Workshop 3: 2025 Australian guideline for the diagnosis and management of hypertension
Tracks
Track 3
| Tuesday, December 9, 2025 |
| 9:00 AM - 11:00 AM |
Details
Heart Foundation in partnership with Stroke Foundation and with input from Hypertension Australia as a key contributor, have prepared the first two modules (likely on diagnostic thresholds, treatment thresholds, treatment targets and measurement methodologies) of the new 2025 Australian Guideline for the Diagnosis and Management of Hypertension.
34 per cent of Australian adults have hypertension, yet only 32 per cent of these individuals achieve adequate blood pressure control, a rate unchanged for over a decade. The National Hypertension Taskforce's Roadmap highlighted the critical need for updated Australian hypertension guidelines and up-to-date, simple blood pressure management tools for healthcare professionals. The new guideline aims to address these challenges by providing updated, evidence-based recommendations tailored to Australia’s healthcare needs.
This workshop aims to unpack the latest evidence and recommendations from the first two modules to help you improve patient outcomes. It will cover the helpful tools available to health professionals to support successful implementation, including decision aids and checklists.
Don't miss this opportunity to hear from members of the Co-Chairs of the expert steering group and discover what’s new in the guideline.
Speaker
Prof Markus Schlaich
Dobney Hypertension Centre - Royal Perth Hospital - University of Western Australia
Presenter
Biography
Prof Markus Schlaich is a renal physician and a European Society of Hypertension (ESH) accredited hypertension specialist. Markus is Chair of Hypertension Australia and Co-Chair of the National Hypertension Taskforce. He has a strong background in clinical research with a focus on the pathophysiology of hypertension, the role of the sympathetic nervous system, involvement of the kidneys, and hypertension mediated organ damage. He has a specific interest in treatment modalities targeting the sympathetic nervous system and has been a pioneer of renal denervation and other interventional approaches. He has authored more than 475 articles in peer reviewed journals and serves on the Editorial Board of Hypertension, Journal of Hypertension, and Hypertension Research.
Dr Dannii Dougherty
Clinical Evidence Manager
Heart Foundation
Presenter
Biography
Mrs Kayla Viney
Executive Officer National Hypertension Taskforce
Stroke Foundation And Heart Foundation
Presenter
Biography
Chair
Garry Jennings AO
Chief Medical Advisor
Heart Foundation
